GAMMA Investing’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.44M Buy
9,295
+841
+10% +$222K 0.08% 180
2026
Q2
$1.87M Sell
8,454
-3,276
-28% -$906K 0.07% 232
2026
Q1
$3.46M Buy
11,730
+1,756
+18% +$522K 0.16% 96
2025
Q4
$2.72M Buy
9,974
+1,762
+21% +$479K 0.14% 113
2025
Q3
$2.22M Sell
8,212
-85
-1% -$23.1K 0.12% 138
2025
Q2
$2.29M Buy
8,297
+1,290
+18% +$351K 0.14% 117
2025
Q1
$1.86M Buy
7,007
+1,381
+25% +$341K 0.14% 132
2024
Q4
$1.31M Buy
5,626
+1,495
+36% +$344K 0.11% 159
2024
Q3
$912K Buy
4,131
+881
+27% +$182K 0.09% 204
2024
Q2
$639K Buy
3,250
+841
+35% +$174K 0.09% 218
2024
Q1
$519K Buy
2,409
+704
+41% +$148K 0.11% 183
2023
Q4
$351K Buy
+1,705
New +$364K 0.1% 183

Other funds holding CME

GAMMA Investing's CME Position: Q3 2026 in Review

GAMMA Investing increased its CME Group (CME) stake by 9.9% in Q3 2026, buying an estimated $222K and bringing the position to 9,295 shares worth $2.44M. The position accounts for 0.08% of the portfolio, ranked #180.

GAMMA Investing first reported a position in CME in Q4 2023 and has held it in 12 quarters since. The position peaked at $3.46M in Q1 2026. 59 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • GAMMA Investing held 9,295 shares of CME Group worth $2.44M as of Q3 2026.
  • GAMMA Investing bought 841 CME Group shares in Q3 2026, an estimated $222K.
  • CME Group made up 0.08% of GAMMA Investing's portfolio in Q3 2026, its #180 holding.
  • GAMMA Investing first reported a position in CME Group in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's CME Group position peaked at $3.46M in Q1 2026.
  • 59 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.